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Submicroscopic chromosomal imbalances in idiopathic
Silver-Russell syndrome (SRS): the SRS phenotype overlaps
with the 12q14 microdeletion syndrome
Abstract
Silver-Russell syndrome (SRS) is a heterogeneous disorder associated with intrauterine and postnatal
growth restriction, body asymmetry, a relative macrocephaly, a characteristic triangular face and further
dysmorphisms. In about 50% of patients genetic/epigenetic alterations can be detected: >38% of patients
show a hypomethylation of the IGF2/H19 imprinting region in 11p15, additional 10% carry a maternal
uniparental disomy of chromosome 7. In single cases, cytogenetic aberrations can be detected.
Nevertheless, there still remain 50% of SRS patients without known genetic/epigenetic alterations. To
find out whether submicroscopic imbalances contribute to the aetiology of SRS we screened 20
idiopathic SRS patients with the Affymetrix GeneChip(R) Human Mapping 500 K array set. Apart from
known apathogenic copy number variations (CNVs) we identified one patient with a 12q14
microdeletion. The 12q14 microdeletion syndrome is characterised by dwarfism but it additionally
includes mental retardation and osteopoikilosis. The deletion in our patient is smaller than those in the
12q14 microdeletion carriers but it also affects the LEMD3 and the HMGA2 genes. LEMD3
haploinsufficiency and point mutations have been previously associated with osteopoikilosis but
radiographs of our patient at the age of 16 years did not reveal any hint for osteopoikilosis lesions.
Haploinsufficiency of HMGA2 is probably responsible for aberrant growth in 12q14 microdeletion
syndrome. However, we excluded a general role of HMGA2 mutations for SRS by sequencing of 20
idiopathic patients. In conclusion, our results exclude a common cryptic chromosomal imbalance in
idiopathic SRS patients but show that chromosomal aberrations are relevant in this disease. Thus
molecular karyotyping is indicated in SRS and should be included in the diagnostic algorithm.
doi:10.1136/jmg.2009.070052 
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Abstract 
 
Silver-Russell syndrome (SRS) is a heterogeneous disorder associated with intrauterine and 
postnatal growth restriction, body asymmetry, a relative macrocephaly, a characteristic 
triangular face and further dysmorphisms. In about 50% of patients genetic/epigenetic 
alterations can be detected: >38% of patients show a hypomethylation of the IGF2/H19 
imprinting region in 11p15, additional 10% carry a maternal uniparental disomy of 
chromosome 7. In single cases, cytogenetic aberrations can be detected. Nevertheless, there 
still remain 50% of SRS patients without known genetic/epigenetic alterations. To find out 
whether submicroscopic imbalances contribute to the aetiology of SRS we screened 20 
idiopathic SRS patients with the Affymetrix GeneChip® Human Mapping 500 K array set. 
Apart from known apathogenic copy number variations (CNVs) we identified one patient 
with a 12q14 microdeletion. The 12q14 microdeletion syndrome is characterised by dwarfism 
but it additionally includes mental retardation and osteopoikilosis. The deletion in our patient 
is smaller than those in the 12q14 microdeletion carriers but it also affects the LEMD3 and the 
HMGA2 genes. LEMD3 haploinsufficiency and point mutations have been previously 
associated with osteopoikilosis but radiographs of our patient at the age of 16 years did not 
reveal any hint for osteopoikilosis lesions. Haploinsufficiency of HMGA2 is probably 
responsible for aberrant growth in 12q14 microdeletion syndrome. However, we excluded a 
general role of HMGA2 mutations for SRS by sequencing of 20 idiopathic patients. 
In conclusion, our results exclude a common cryptic chromosomal imbalance in idiopathic 
SRS patients but show that chromosomal aberrations are relevant in this disease. Thus 
molecular karyotyping is indicated in SRS and should be included in the diagnostic algorithm. 
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Sirs - 
 
Silver-Russell syndrome (SRS, OMIM180860) is a clinically and genetically heterogeneous 
disorder which is mainly characterised by severe intrauterine and postnatal growth retardation 
and a characteristic small, triangular face. The disease is associated with failure to thrive and 
additional dysmorphic features including fifth finger clinodactyly and hemihypoplasia. 
Although a clinical scoring system to assist the diagnosis has recently been suggested 1, the 
accuracy of diagnosis is influenced by the experience of the clinical investigator. 
Furthermore, the clinical picture of SRS in adulthood is less clear than in early childhood.  
The clinical heterogeneity is reflected by the heterogeneous genetic/epigenetic findings in 
SRS patients: in about 10% of cases a maternal uniparental disomy of chromosome 7 
(UPD(7)mat) can be detected, whereas >38% carry a methylation defect in the telomeric 
imprinted region on chromosome 11p15 (for review: 2). Indeed, the 11p15 epimutation 
carriers often show the more typical SRS phenotype while UPD(7)mat carriers are milder 
affected (for review: 3). Nevertheless, many exceptions have been reported thereby making a 
strict genotype-phenotype correlation impossible. In addition to these two major disturbances, 
several SRS patients carry microscopic detectable structural aberrations affecting numerous 
chromosomes, but only chromosomes 7, 11 and 17 were repeatedly involved in individuals 
fulfilling strict diagnostic criteria of SRS (fig. 1).  
Up to now, chromosomal analysis in SRS has been based on conventional karyotype analysis 
but a systematic screen for (sub)microscopic disturbances has not yet been performed. With 
the development of array based genomic screening techniques, a new powerful tool for 
detection of cryptic imbalances has recently become available. While several new 
microdeletion syndromes have been identified using genomic array technology (for review: 4), 
the search for genomic imbalances has nearly always been focused on patients with mental 
retardation and facultative clinical features. The need to check SRS patients for 
submicroscopic chromosomal imbalances was recently illustrated by the identification of two 
SRS patients carrying 11p15 duplications with a size of 1 Mb and 5.6 Mb respectively (for 
review: 2). 
We screened a cohort of idiopathic SRS patients for cryptic chromosomal imbalances by 
single-nucleotide polymorphism oligonucleotide arrays (SNP array) thereby identifying one 
carrier of a 12q14 microdeletion. Within this region, the gene of the nonhiston chromosomal 
protein HMGA2 is localised.  The identification of a HMGA2 mutation in the “pygmy” mouse 
indicated that HMGA2 plays a role in aberrant growth and development. 5 We therefore 
sequenced the coding region of HMGA2 in the deletion carrier as well as in 19 further SRS 
patients without 11p15 epimutation. 
 
The study population consisted of 20 patients with SRS, ascertained as part of ongoing 
molecular investigations on SRS. The diagnosis of SRS was based on the following criteria: 
intrauterine growth retardation (birth weight or length below the 3rd percentile), lack of 
postnatal catch-up growth, and at least two of the following criteria: typical face, relative 
macrocephaly, and skeletal asymmetry. In all patients, 11p15 epimutation and UPD(7)mat 
had previously been excluded. The study was approved by the ethical committee of the 
University Hospital Aachen. 
 
Genomic DNA of the probands was isolated from peripheral lymphocyte cells by a simple 
salting-out procedure.  
All samples were investigated by micorarray typing. The used 500 K array (Affymetrix, High 
Wycombe, UK) consists of two arrays, the NspI kit and the StyI kit which together include 
>500,000 SNPs. DNA was processed according to the manufacturers instructions. 
Hybridisation and washing was performed according to the manufacturer´s manual. Arrays 
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were recorded using an Affymetrix GeneChip®Scanner 3000 7G. Data processing including 
quality assessment was performed using the “R” statistical framework (http://www.r-
project.org) with dedicated extensions from the “aroma.affymetrix” project. 6 Copy number 
segmentation results were visualised using tools developed for the Progenetix project 
(http://www.progenetix.net; 7). The 12q14 microdeletion was then confirmed by quantitative 
PCR and by typing of the Affymetrix GeneChip®Genome-Wide Human SNP 6.0 array. 
Direct sequencing of the coding region of the HMGA2 gene was performed by using the 
BigDyeTerminatorCycleSequencing System (Applied Biosystems, Weiterstadt, Germany). 
Primers and PCR conditions are available on request. Samples were electrophoresed on an 
automatic ABI3130 sequencing system (Applied Biosystems). 
 
Apart from numerous known apathogenic copy number variations (CNVs) in each patient, we 
identified altogether 7 different so far unregistered copy number alterations (CNAs) in 5 of 
the 20 patients (table 1). Six affected regions did not harbour genes and were therefore 
excluded from further analysis. However, the screening for submicroscopic imbalances in 20 
idiopathic SRS patients did not provide evidence for a common chromosomal aberration in 
this syndrome. This finding is not surprising if we consider the extreme clinical but also 
genetic/epigenetic heterogeneity in this disease. Also, this observation is in line with reports 
from other genomic screening studies reporting the heterogeneity of pathological CNAs in 
patients analysed due to one or related phenotypical studies (e.g. studies on mental 
retardation, epilepsy autism; for review: 4). 
Nevertheless, the identification of one among 20 so far idiopathic SRS patients carrying a 
microdeletion underlines the necessity to routinely test SRS patients by molecular 
karyotyping. 
 
In this patient (SR29), we detected a de-novo 1.35 Mb deletion in 12q14, among others the 
deletion includes the LEMD3 and the HMGA2 genes (fig. 2). The girl was the second child of 
healthy unrelated parents. Her father´s height is 185 cm, her mother´s height is 166 cm. 
Family history is unremarkable. 
Intrauterine growth retardation was noted in the 20th week of pregnancy. The child was born 
at term, length at birth was 46 cm (-2.59 standard deviation (SD)), weight was 2700 g (-1.83 
SD). Apgar scores were 10 and 10. Psychomotoric development was unremarkable. Feeding 
difficulties and a squeaky voice were reported. At an age of 1 year and 9 months, the girl 
spoke 10 words. 
The patient was referred for clinical evaluation at age 1 9/12 years, her height was 70.8 cm (-
4.5 SD), weight was 6800 g (-5.4 SD), OFC was 43.7 cm (- 3.3 SD) (table 2). In addition to 
relative macrocephaly she presented a prominent forehead, a slightly triangular face, slightly 
dysplastic ears, and clinodactyly of the fifth digit. She showed no evidence for lateral 
asymmetry or skeletal abnormalities.  
At the age of 16 years, radiographic evaluation of the right tibia and fibula as well as the right 
foot did not reveal any lesions. A convex scoliosis was noted. The girl successfully visits a 
grammar school (“Gymnasium”). 
 
Sequencing of the coding region of the HMGA2 gene in 12q14 which was deleted in patient 
SR29 did not reveal any pathogenic mutation neither in the remaining HMGA2 copy of 
patient SR29 nor in the 19 additionally sequenced idiopathic SRS patients. 
 
Interestingly, SRS patients share clinical features with one of these recently defined 
microdeletion disorders, the 12q14 microdeletion syndrome. This entity was firstly reported 
by Menten et al. 8 and is characterised by failure to thrive in infancy, osteopoikilosis, short 
stature and mental retardation. In one of these cases the diagnosis of SRS was considered but 
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then discarded. The three unrelated patients carried deletions ranging from 3.44 Mb to 6 Mb 
(fig. 2). Among other genes, in all patients the LEMD3 gene was deleted which was 
previously shown to be the causal gene for osteopoikilosis (for review: 8), an uncommon and 
usually asymptomatic benign sclerosing bone dysplasia. Two further genes in the common 
deleted regions were GRIP1 and HMGA2. The glutamate receptor interacting protein 1 
(GRIP1) is highly expressed in fetal and adult human brain, and involved in glutameric 
synaptic transmission, thus a correlation between GRIP1 haploinsufficiency and learning 
problems in the 12q14 microdeletion carriers has been proposed. For HMGA2 an important 
role in human growth as well as in lipomatosis has been postulated. 8, 9 The significance of 
HMGA2 for human growth was supported by the identification of a fourth patient with a 
smaller 12q14 deletion 10(fig. 2): in this patient the deletion affected six genes, among others 
HMGA2 and GRIP1, but not LEMD3. Indeed, this patient did not show radiological signs of 
osteopoikilosis but pre- and postnatal growth retardation, failure to thrive and mild 
developmental delay. Interestingly, a clinical diagnosis of SRS was also considered in this 
patient.  
 
The findings in our patient underline the clinical overlap between SRS and 12q14 
microdeletion syndrome (table 2). However, in contrast to the other four microdeletion 
carriers reported so far, our patient is not mentally handicapped; this observation is consistent 
with the finding that the GRIP1 gene is not affected by the deletion in our patient. 
Interestingly, at an age of 16 years our patient does not show radiographic features consistent 
with osteopoikilosis despite the association of LEMD3 haploinsufficiency with this rare 
benign sclerosing bone dysplasia. However, the age of osteopoikilosis manifestation is 
currently unknown, thus we assume that they might occur later in life in our patient. Like in 
the other microdeletion 12q14 patients, in our patient the HMGA2 gene is deleted. Point 
mutations were not detectable in this patient, we therefore agree with Mari et al.10 that 
haploinsufficiency of this gene is sufficient to cause growth retardation. However, by 
screening another 20 SRS patients for point mutations in HMGA2 we did not obtain evidence 
for a significant role of this gene for the aetiology of SRS. 
 
Up to now, all screening studies for submicroscopic chromosomal imbalances were focused 
on patients with mental retardation as the main clinical feature. Our data as well as recently 
published reports on single growth retarded patients with cryptic imbalances, i.e. in 11p15 11, 
12, show that loss or gain of genomic fragments with a size of several Mb does not 
automatically cause intellectual incapacities. Indeed, genomic copy number alterations should 
generally be considered in patients with intrauterine and postnatal growth retardation and 
minor further anomalies but with normal intelligence. In SRS, molecular karyotyping should 
be included in the diagnostic algorithm.  
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patient chromosome gain/loss size genes affected Interpretation 
SR29 12q14 loss 1.3 Mb yes (see fig. 2) CNA 
SR115 8q21 gain 710 kb no CNV 
 16q21 loss 12 kb no CNV 
SR89 9p23 loss 103 kb no CNV 
SR95 18q22 loss 51 kb no CNV 
SR104 6q12 loss 43.1 kb no CNV 
SR63 14q12 loss 4 kb no CNV 
 
Table 1: Overview on the 6 patients identified by 500K microarray typing as carriers of 
so far unreported (de-novo) CNVs/CNAs, and the affected regions. 
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SRS features General SRS 
population 13 
General SRS 
population  
(n=50)14 
12q14 
microdeletion 
carriers* 
(n=4)8,10 
our patient* 
Birth weight <3rd 
percentile 
94% 86% 2/4 + 
Short stature 99% 86% 4/4 + 
Hemihypotrophy 51% 34% 0/4 - 
Muscular hypotrophy/-
tony 
45%  1 /4 - 
Relative macrocephaly 64% 70% 1 /4 + 
Triangular face 79% 62% 1 /4 (+) 
Down-slanting corners of 
the mouth 
46%  1 /4 - 
Irregular teeth 28%  -  
Ear anomalies 53%  - - 
Clinodactyly V 68% 56% - + 
Brachydactyly V 48%  - - 
Syndactyly of toes II/III 19%  - - 
Simian crease 25%  - - 
Café-au-lait spots 19% 4% - - 
Psychomotor retardation 37% 38% 4/4 - 
Speech delay  20% 2/2 - 
Squeaky voice 22%   - 
Feeding difficulties  56% 4/4 - 
     
12q14 microdeletion 
features 
    
Mental retardation - - 4/4 - 
Osteopoikilosis - - ¾ Not present at 
the age of 16 
years 
 
Table 2: Clinical features of SRS patients, of 12q14 microdeletion carriers and our case. 
(* the different sizes of the deletions in these cases have to be considered) 
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Figure 1. Chromosomal aberrations and UPDs in SRS: Review on types, frequencies and 
affected genomic regions. A complete list of references describing chromosomal aberrations 
in SRS is available on request. The 12q14 microdeletion in our patient is indicated by an 
arrow. 
 
 
Figure 2. Local Affymetrix Genotyping 6.0 signal distribution pattern and segmentation 
result in patient SR29 (SR0029). A deletion in 12q14 can be observed, affecting the whole 
HMGA2 and LEMD3 coding regions and overlapping with the previously reported 12q14 
microdeletion syndrome as illustrated by the DECIPHER entries. 
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